Korea to ease reg­u­la­tions on stem cell re­search

BioSpectrum (Asia) - - Regulatory News -

The South Korean govern­ment is plan­ning to ease reg­u­la­tions on em­bry­onic stem cell re­search and gene ther­apy prod­uct de­vel­op­ment for the bet­ter­ment of the biotech in­dus­try. Re­cently, the Min­istry of Health and Wel­fare stated that the al­low­able range of em­bry­onic stem cell and ge­netic scis­sors re­search would be ex­panded to the same level as ad­vanced coun­tries. Var­i­ous re­stric­tions are cur­rently im­posed on re­search and de­vel­op­ment of em­bry­onic stem cells, in­clud­ing hu­man em­bryo, and so­matic cell-based gene ther­a­pies. The re­search on em­bry­onic stem cells is only al­lowed for 20 types of rare and in­cur­able dis­eases, while that on gene ther­a­pies is al­lowed for se­vere dis­eases such as ge­netic dis­or­der, cancer and AIDS. The in­dus­try has high­lighted that there are ex­ces­sive reg­u­la­tions on the re­search ar­eas and strongly asked to in­tro­duce neg­a­tive regulation sys­tem, which per­mits re­search first if it is for treat­ment and im­pose reg­u­la­tions later.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.